Search results
Results From The WOW.Com Content Network
Streptococcus agalactiae is the most common human pathogen belonging to group B of the Lancefield classification of streptococci—hence the name of group B stretococcal (GBS). Infection with GBS can cause serious illness and sometimes death, especially in newborns, the elderly, and people with compromised immune systems .
Streptococcus agalactiae (also known as group B streptococcus or GBS) is a gram-positive coccus (round bacterium) with a tendency to form chains (as reflected by the genus name Streptococcus). It is a beta- hemolytic , catalase -negative, and facultative anaerobe .
Cefazolin is pregnancy category B, indicating general safety for use in pregnancy. Caution should be used in breastfeeding as a small amount of cefazolin enters the breast milk. [8] Cefazolin can be used prophylactically against perinatal Group B streptococcal infection (GBS).
Group B streptococcus (GBS), also named Streptococcus agalactiae, is a bacteria typically identified as the cause of the majority of early-onset infections in the neonate. GBS is an encapsulated gram-positive cocci that colonizes the gastrointestinal and genital tracts of pregnant women.
Group B strep is an infection that may be passed to an infant during birth. Vaginal screening for GBS is performed between 34 and 37 weeks of gestational age, so that mothers that are positive for the bacterium can receive treatment before delivery.
Pregnant and postpartum women have a higher risk of developing an invasive group A strep infection. “It is probably related to some of the physiological changes associated with pregnancy and the ...
Similarly, group B streptococcus typically denotes Streptococcus agalactiae, although minor beta-hemolytic group B streptococci like S. troglodytidis exist. [15] While most streptococcal illnesses in humans originate from species adapted to humans, such as S. pneumoniae or S. pyogenes , there are zoonotic species capable of causing infections ...
They are also used in late pregnancy for reducing neonatal infectious mortality and morbidity due to group B streptococcal infections; [4] nonetheless, hexetidine is to be used with care during pregnancy, and its vaginal use is counter-indicated in the first three months of pregnancy. [5] Hexetidine